- Edwards Lifesciences ( NYSE: EW ) has announced the planned retirement of chairman and CEO, Michael Mussallem.
- At the company's 2023 annual meeting on May 11, 2023, Mussallem will stand for election as non-executive chairman of Edwards' board.
- Bernard Zovighian, currently corporate vice president and general manager for Edwards' Transcatheter Mitral and Tricuspid Therapies business, will succeed Mussallem as CEO. Zovighian will serve as president of Edwards Lifesciences effective Jan. 1 until he becomes CEO in May.
For further details see:
Edwards Lifesciences CEO Michael Mussallem to retire